RegulatoryOfficial

MHRA publishes Women's Health Programme for 2026-2030 to strengthen evidence and regulation

🇬🇧 MHRA · Mon 16 Nov 2026

The UK regulator's 32-page corporate report aims to improve the safety and effectiveness of medicines and medical devices used by women, within its wider strategy to 2030.

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its Women's Health Programme 2026-2030, a corporate report setting out how it intends to improve the evidence base and regulation of medicines and medical devices so that health outcomes for women improve. The document was published on 16 November 2026 and runs to 32 pages.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Official source: MHRA ↗

Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.

More Regulatory All →